A Single-center Prospective Cohort Study for Pure Pulmonary Ground Glass Nodules in Women Preparing for Pregnancy
1 other identifier
observational
200
1 country
1
Brief Summary
In this study, about 200 pure GGO in women preparing for pregnancy will be included for a 5-year follow-up. The aim of this study is to elucidate the biological nature of pulmonary GGO lesion in women preparing for pregnancy and provide evidence for GGO treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedOctober 22, 2020
January 1, 2020
2.2 years
October 11, 2020
October 15, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Changes from baseline GGO diameter
Changes from baseline GGO diameter
6 months, 1year, 2 years, 3 years, 4 years and 5 years
Changes from baseline GGO CT index.
Changes from baseline GGO CT index.
6 months, 1year, 2 years, 3 years, 4 years and 5 years
Interventions
pure pulmonary ground glass nodules in women preparing for pregnancy
Eligibility Criteria
pure pulmonary ground glass nodules in women preparing for pregnancy
You may qualify if:
- \- 20-45 years' old found pulmonary GGO with chest CT scan and CT follow-up after 3 months shows that the GGO remains Diameter of GGO \> 5mm and \< 3cm
You may not qualify if:
- \- receiving immunosuppressor or steriods receiving chemo- or radio- therapy can not receive regular follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongshan Hospital
Shanghai, Shanghai Municipality, 20032, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2020
First Posted
October 22, 2020
Study Start
November 1, 2020
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
October 22, 2020
Record last verified: 2020-01